The long-term incidence of hospitalization for ketoacidosis in adults with established T1D-a prospective cohort study
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Context: The long-term natural history of diabetic ketoacidosis (DKA) and its risk factors are poorly understood. Objective: To determine the long-term incidence and predictors of DKA in adults with longstanding type 1 diabetes (T1D). Design: All hospitalizations and deaths due to DKA between 1996 and 2016 were identified in 4758 adults with T1D from the Finnish Diabetic Nephropathy Study (FinnDiane), and a cohort of 16 224 adults with T1D from the Finnish general population. Results: Between 1996 and 2015, there were 1228 DKA events in the FinnDiane participants (1.4/100 person-years) and 4914 DKA events (1.8/100 person-years) in adults with T1D from the general population. The majority were hospitalized only once. There was a modest increase in the frequency of DKA in the FinnDiane over the follow-up (~2.4%/year [95% CI, 0.3–4.5%]; P = 0.03). Predictors of DKA were glucose control, CSII, smoking and alcohol consumption, and raised high-density lipoprotein cholesterol and triacylglycerides. Diabetic nephropathy and renal impairment were associated with DKA; patients with end-stage renal disease, macroalbuminuria, and microalbuminuria had 2.09-fol (95% CI, 1.40–3.12), 1.65-fold (95% CI, 1.23–2.19), and 0.87-fold (95% CI, 0.61–1.24) risk of DKA compared with patients with normal albumin excretion rate, respectively. Patients with an estimated glomerular filtration rate <60 mL/min/1.73 m2 were also more likely to be hospitalized for DKA (HR 1.71 [95% CI, 1.26–2.67]). Conclusions: DKA remains a common cause of hospitalization in individuals with longstanding T1D. These data suggest that the goal to use SGLT2 inhibitors for their vasculo- and renoprotective actions may be problematic, as those most likely to benefit may also have the highest risk for DKA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Zelniker, T. A., Wiviott, S. D., Raz, I., Im, K., Goodrich, E. L., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Furtado, R. H. M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32590-x · Cited by 2,845
Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study
Harjutsalo, V., Sjöberg, L., & Tuomilehto, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60765-5 · Cited by 666
Self-citation(2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.193 · Cited by 653
Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010
Livingstone, S. J., Levin, D., Looker, H. C., Lindsay, R. S., Wild, S. H., Joss, N., Leese, G., Leslie, P., McCrimmon, R. J., Metcalfe, W., et al. (2015) · JAMA · doi:10.1001/jama.2014.16425 · Cited by 621
Metabolic Syndrome in Type 1 Diabetes
Thorn, L. M., Forsblom, C., Fagerudd, J., Thomas, M. C., Pettersson-Fernholm, K., Saraheimo, M., Wadén, J., Rönnback, M., Rosengård-Bärlund, M., Björkesten, C.-G. A., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.2019 · Cited by 423
Self-citationEmpagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials
Rosenstock, J., Marquard, J., Laffel, L. M., Neubacher, D., Kaspers, S., Cherney, D. Z., Zinman, B., Skyler, J. S., George, J., Soleymanlou, N., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1749 · Cited by 363
Benoit, S. R., Zhang, Y., Geiss, L. S., Gregg, E. W., & Albright, A. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6712a3 · Cited by 334
Recurrent Diabetic Ketoacidosis in Inner-City Minority Patients
Randall, L., Begovic, J., Hudson, M., Smiley, D., Peng, L., Pitre, N., Umpierrez, D., & Umpierrez, G. (2011) · Diabetes Care · doi:10.2337/dc11-0701 · Cited by 207
Herttua, K., Makela, P., & Martikainen, P. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn216 · Cited by 206
Desai, D., Mehta, D., Mathias, P., Menon, G., & Schubart, U. K. (2018) · Diabetes Care · doi:10.2337/dc17-1379 · Cited by 206
Zhong, V. W., Juhaeri, J., & Mayer-Davis, E. J. (2018) · Diabetes Care · doi:10.2337/dc17-1583 · Cited by 177
Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study
Harjutsalo, V., Forsblom, C., & Groop, P.-H. (2011) · BMJ · doi:10.1136/bmj.d5364 · Cited by 173
Self-citationPala, L., Dicembrini, I., & Mannucci, E. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01326-5 · Cited by 112
International Evaluation of Cause-Specific Mortality and IDDM
Diabetes Epidemiology Research International Mortality Study Group (1991) · Diabetes Care · doi:10.2337/diacare.14.1.55 · Cited by 99
Harjutsalo, V., Thomas, M. C., Forsblom, C., Groop, P., & On Behalf of the FinnDiane Study Group (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13456 · Cited by 53
Self-citationWright, J., Ruck, K., Rabbitts, R., Charlton, M., De, P., Barrett, T., Baskar, V., Kotonya, C., Saraf, S., & Narendran, P. (2009) · The British Journal of Diabetes & Vascular Disease · doi:10.1177/1474651409353248 · Cited by 47
Groop, P., Thomas, M. C., Feodoroff, M., Forsblom, C. M., & Harjutsalo, V. (2018) · Diabetes Care · doi:10.2337/dc17-1618 · Cited by 47
Self-citationSanjeevi, N., Lipsky, L. M., & Nansel, T. R. (2018) · Nutrients · doi:10.3390/nu10101552 · Cited by 37
Galler, A., Bollow, E., Meusers, M., Bartus, B., Näke, A., Haberland, H., Schober, E., & Holl, R. W. (2015) · Diabetes Care · doi:10.2337/dc14-2538 · Cited by 33
Data-driven metabolic subtypes predict future adverse events in individuals with type 1 diabetes
on behalf of the FinnDiane Study Group, Lithovius, R., Toppila, I., Harjutsalo, V., Forsblom, C. M., Groop, P., & Mäkinen, V. (2017) · Diabetologia · doi:10.1007/s00125-017-4273-8 · Cited by 23
Self-citationCalderon, R. M., Diaz, S., Szeto, A., Llinas, J. A., Hughes, T. A., Mendez, A. J., & Goldberg, R. B. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1357 · Cited by 20
Butalia, S., Johnson, J. A., Ghali, W. A., Southern, D. A., & Rabi, D. M. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12336 · Cited by 15
Butalia, S., Patel, A. B., Johnson, J. A., Ghali, W. A., & Rabi, D. M. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.08.224 · Cited by 7
Risk factors for recurrent admissions with diabetic ketoacidosis: importance of mental health
Simmons, D. S., Hartnell, S., Davenport, K., & Jenaway, A. (2016) · Diabetic Medicine · doi:10.1111/dme.13202 · Cited by 3
Cited by
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s006 · Cited by 440
Hyperglycemic crises in adults with diabetes: a consensus report
Umpierrez, G. E., Davis, G. M., ElSayed, N. A., Fadini, G. P., Galindo, R. J., Hirsch, I. B., Klonoff, D. C., McCoy, R. G., Misra, S., Gabbay, R. A., et al. (2024) · Diabetes Care · doi:10.2337/dci24-0032 · Cited by 278
Roussel, R., Riveline, J.-P., Vicaut, E., de Pouvourville, G., Detournay, B., Emery, C., Levrat-Guillen, F., & Guerci, B. (2021) · Diabetes Care · doi:10.2337/dc20-1690 · Cited by 173
Hyperglycaemic crises in adults with diabetes: a consensus report
Umpierrez, G. E., Davis, G. M., ElSayed, N. A., Fadini, G. P., Galindo, R. J., Hirsch, I. B., Klonoff, D. C., McCoy, R. G., Misra, S., Gabbay, R. A., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06183-8 · Cited by 228
“…hyperglycaemic crisis in people with type 1 diabetes include younger age, prior history of hyperglycaemic and hypoglycaemic crises, presence of kidney disease, neuropathy, depression, smoking, alcohol and substance abuse, high HbA 1c and social determinants of health (SDOH) [1, 6, 7, 16, 55, 58].”
Ehrmann, D., Kulzer, B., Roos, T., Haak, T., Al-Khatib, M., & Hermanns, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30042-5 · Cited by 141
Metadata
- Authors
- Thomas, M., Harjutsalo, V., Feodoroff, M., Forsblom, C., Gordin, D., & Groop, P.-H.
- Affiliations
- Monash University (AU)
- University of Helsinki (FI)
- Corresponding author
- Groop, Per-Henrik
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2019-09-14
- Volume
- 105
- Issue
- 1
- Pages
- 231-241
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2974642597
- Cited by
- 30
- References
- 24
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 5 · 2023: 6 · 2022: 3 · 2021: 3 · 2020: 2
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Työväentutkimus Vuosikirja (submittedVersion, other-oa)
- Funders
- Folkhälsan Research Foundation (316664)
- Wilhelm and Else Stockmann Foundation
- Novo Nordisk Foundation (OC0013659)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- diabetic ketoacidosis, type 1 diabetes, incidence, risk factors, diabetic nephropathy, renal dysfunction, end-stage renal disease, albuminuria, estimated glomerular filtration rate, insulin pump therapy, glycemic control, SGLT2 inhibitors, adults with type 1 diabetes
- MeSH terms
- Adolescent, Adult, Blood Glucose, Child, Child, Preschool, Diabetes Mellitus, Type 1, Female, Finland, Follow-Up Studies, Hospitalization, Humans, Infant, Infant, Newborn, Male, Middle Aged, Prognosis, Prospective Studies, Retrospective Studies, Risk Factors, Biomarkers, Incidence, Diabetic Ketoacidosis, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.